GlassScriptPhysician profile
Zuri D Hemphill
NPI 1427580711
$3,558.62
in general payments reported to CMS, 2019-2025
32 companies · $880 in 2025
The $880 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.32 · 2020: $13.36 · 2021: $619 · 2022: $401 · 2023: $1,064 · 2024: $563 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,228 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,227.53 |
| Education | $279.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $556.94 | 2023-2025 | Veozah, Myrbetriq |
| Baxter Healthcare | $467.32 | 2021-2025 | Floseal, Tisseel, Perclot |
| Mayne Pharma Commercial LLC | $389.51 | 2022-2025 | |
| Hologic Sales and Service, LLC | $379.25 | 2021-2025 | Aptima, Coolseal Generator |
| Aspira Women'S Health INC | $246.95 | 2022-2023 | Ova1 |
| Pfizer INC. | $155.42 | 2021-2024 | |
| Evofem Biosciences, INC. | $139.89 | 2024-2025 | Phexxi, Solosec, Phexx |
| Lsi Solutions INC | $126.58 | 2023 | Ti Knot, Running Device |
| Exeltis, USA INC. | $117.41 | 2022-2023 | Slynd |
| Biogen, INC. | $111.97 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $97.52 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $94.45 | 2024-2025 | Myfembree, Gemtesa |
| Mimedx Group, INC. | $85.58 | 2024 | |
| Integra Lifesciences Corporation | $81.71 | 2023 | Biodrestore, Biodfactor, Biodoptix |
| Millicent US INC | $67.65 | 2025 | Femlyv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $59.55 | 2021-2023 | |
| Organon LLC | $51.40 | 2024 | |
| Medtronic, INC. | $38.34 | 2024 | Interstim |
| Sage Therapeutics, LLC | $33.03 | 2023 | |
| Therapeuticsmd, INC. | $30.84 | 2021-2022 | |
| Boston Scientific Corporation | $30.68 | 2019-2020 | |
| Coopersurgical, INC. | $27.21 | 2023 | Endosee, Paragard T 380a |
| Shield Therapeutics INC | $22.91 | 2022 | |
| Convatec INC. | $22.03 | 2023 | |
| Dexcom, INC. | $20.77 | 2023 | Dexcom G6 Transmitter |
| Hydrofera LLC | $17.22 | 2025 | Hydrofera Blue |
| Agile Therapeutics, INC. | $16.62 | 2023 | Twirla |
| Optumhealth Care Solutions, LLC | $16.30 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Gilead Sciences, INC. | $15.15 | 2025 | |
| Exact Sciences Corporation | $15.08 | 2023 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $12.49 | 2021 | |
| Meditrina | $10.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zuri Hemphill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.